How should I manage persistent skin picking (excoriation disorder) in a patient currently taking duloxetine 60 mg daily and quetiapine 25 mg at bedtime?

Management of Persistent Skin Picking on Current Medications

You should optimize the duloxetine dose first by increasing to 120 mg daily, as the current 60 mg dose is subtherapeutic for excoriation disorder, and consider adding N-acetylcysteine (NAC) 1200-2400 mg daily if symptoms persist after adequate duloxetine trial. The quetiapine 25 mg is too low to provide meaningful therapeutic benefit and should be reassessed.

Understanding the Current Regimen

Your current medications are underdosed for treating excoriation (skin-picking) disorder:

• Duloxetine 60 mg: While this is a standard dose for depression/anxiety, evidence suggests higher doses may be needed for body-focused repetitive behaviors 1
• Quetiapine 25 mg: This dose is primarily sedating and lacks the dopaminergic modulation that occurs at therapeutic antipsychotic doses (typically 200-400 mg for psychiatric conditions) 2

The key issue is that excoriation disorder is distinct from body dysmorphic disorder (BDD) - skin picking in excoriation disorder is not driven by appearance concerns, whereas in BDD it's specifically to "fix" perceived defects 3. This distinction matters for treatment selection.

Evidence-Based Treatment Algorithm

Step 1: Optimize Current SNRI Therapy

Increase duloxetine to 120 mg daily over 2-4 weeks:

• Start by adding 30 mg to current dose (90 mg total)
• After 1-2 weeks, increase to 120 mg if tolerated
• Monitor for nausea, blood pressure changes, and liver function 1
• Allow 8-12 weeks at maximum dose for adequate trial 4

Rationale: SNRIs show promise for excoriation disorder, and duloxetine specifically has demonstrated efficacy at higher doses (60-120 mg) for chronic pain conditions involving repetitive behaviors 1. A 2025 systematic review found SSRIs/SNRIs show the most promising results for reducing skin-picking severity and frequency 4.

Step 2: Add Glutamatergic Agent if Partial Response

Add N-acetylcysteine (NAC) 1200-2400 mg daily:

• Start 600 mg twice daily
• Increase to 1200 mg twice daily after 1 week if tolerated
• This is well-established for excoriation disorder 5
• Generally well-tolerated with minimal drug interactions

Evidence: NAC has been specifically studied for skin-picking disorder and shows benefit in multiple trials 6, 5. A 2016 systematic review found behavioral treatments and NAC had the strongest evidence base 6.

Step 3: Reassess the Quetiapine

The current 25 mg dose serves no clear therapeutic purpose:

Options:

1. Discontinue if only being used for sleep (consider trazodone 50-100 mg instead if needed)
2. Increase to therapeutic range (150-300 mg) only if there are comorbid psychotic features, severe agitation, or treatment-resistant symptoms 2

Caution: At 25 mg, quetiapine provides only antihistaminic sedation without meaningful dopaminergic or serotonergic effects. Higher doses carry metabolic risks and should be reserved for specific indications 7.

Critical Monitoring Points

Safety Concerns with Duloxetine Dose Escalation

• Hepatotoxicity: Watch for right upper quadrant pain, jaundice, dark urine 1
• Blood pressure: SNRIs can cause sustained hypertension - check BP regularly 8
• Serotonin syndrome risk: Especially if combining with other serotonergic agents 1
• Discontinuation syndrome: Never stop abruptly - taper slowly if needed 8

When to Consider Behavioral Therapy

Habit reversal therapy or acceptance-enhanced behavior therapy should be initiated concurrently with medication optimization 6, 5. A 2016 meta-analysis found that only behavioral treatments demonstrated significant benefits compared to placebo in RCTs - medications alone showed improvement but not significantly better than placebo 6.

Alternative Medications if Above Fails

If duloxetine optimization plus NAC fails after 12 weeks:

1. Switch to fluoxetine 60-80 mg daily (most studied SSRI for excoriation disorder) 4, 6
2. Consider mirtazapine 30-45 mg at bedtime (antihistaminergic effect may help with skin itching/urges) 9
3. Naltrexone 50-100 mg daily (opioid antagonist, may reduce urge/reward cycle) 4, 5

Avoid: Lamotrigine showed no benefit over placebo in RCTs for skin-picking disorder 6.

Common Pitfalls to Avoid

• Don't assume this is OCD: While excoriation disorder is classified with OCD-related disorders, the treatment response differs. Pure OCD treatments may not work 10
• Don't continue ineffective low-dose medications: The quetiapine 25 mg is pharmacologically inactive for psychiatric purposes
• Don't expect rapid response: Allow 8-12 weeks at therapeutic doses before declaring treatment failure 4
• Don't neglect behavioral therapy: Medication alone has limited evidence; combination treatment is superior 6, 5

Timeline Expectations

• Weeks 1-4: Titrate duloxetine to 120 mg, add NAC
• Weeks 4-12: Assess response at therapeutic doses
• Week 12: If <30% improvement, consider switching to fluoxetine or adding augmentation
• Ongoing: Continue behavioral therapy throughout

The evidence strongly suggests that your current regimen is underdosed and that optimization of the SNRI combined with NAC and behavioral therapy offers the best chance of symptom control 4, 6, 5.